Overview
Diabetes mellitus is one of the most common co-existing conditions in people living with cancer — and when unmanaged, it can significantly affect treatment tolerance, outcomes and patient wellbeing.
This course offers a rare opportunity to explore both conditions together, combining cutting-edge research with practical clinical updates. Whether you work in oncology, diabetes care or a related field, this on-demand programme will enhance your confidence and capability to support this growing patient group.
Key information
Online (fully on-demand)
Self-paced access with personalised login link
Delivery style
- Lecture-based presentations
- Case studies
- Video content
- Optional resources
Duration
One pre-recorded session (self-paced)
Experience level
Any level
09:00 Registration
09:30 Welcome & Introductions
09:40 Updates on Diabetes – Dr Maria Michaelidou
10:20 Cancer Drugs & Diabetes – Dr Jamie Weaver
10:55 Break
11:20 Immune Checkpoint Inhibitor–Induced Diabetes – Dr Safwaan Adam
12:00 Panel Discussion: How to Set Up a Diabetes & Cancer Service
12:35 Diabetes & Neuropathy – Dr Shazli Azmim
13:00 Lunch
14:00 Interdisciplinary Approach to Diabetes, Obesity & Cancer – Dr Emma Vincent
14:30 Patient Journey with Cancer
15:00 Break
15:20 Clinical Case with Diabetes – Panel
16:30 End of Day
Silver sponsor
Bronze sponsors
What to expect
Diabetes is one of the most common comorbidities seen in people living with cancer — yet managing both conditions together can be complex. This on-demand webinar brings together leading clinicians to explore the latest evidence, clinical insights and real-world considerations in supporting patients with both cancer and diabetes.
Accessible anytime, this session offers a flexible, high-quality learning experience that fits around your schedule. Once purchased, you'll receive your own personalised link to an on-demand page containing:
- The full pre-recorded webinar
- Speaker information
- Downloadable slides
- Any additional resources provided by the expert faculty
Designed to deepen your understanding and enhance your practice, this on-demand course provides practical, clinically relevant knowledge to support integrated, person-centred care.
Topics include:
- The relationship between diabetes and cancer
- How cancer treatments impact blood glucose levels
- Case studies from clinical practice
- Multidisciplinary approaches to managing dual diagnoses
Learning outcomes
By the end of the course, you will be able to:
Understand current evidence on the link between diabetes and cancer
Recognise how cancer treatments influence diabetes control
Apply practical strategies to support patients with both conditions
Explore MDT approaches to complex comorbidity management
Who is it for?
Healthcare professionals supporting patients with cancer, diabetes or both, including:
- Nurses
- Doctors
- AHPs
- Pharmacists
- Primary care professionals
How to book / learn more
Eventbrite:
On-Demand: Updates in Diabetes and Cancer
Not ready to book? Find out more
What's new?
The Christie Institute news-
Read more about The beginning of an international partnership between The Christie and the National Cancer Institute of UkraineThe beginning of an international partnership between The Christie and the National Cancer Institute of Ukraine
The Christie Institute for Cancer Education has welcomed international colleagues from the National Cancer Institute of Ukraine (UNCI) as part of a new education partnership focused on bilateral sharing of knowledge.
-
Read more about International newsletter 2025International newsletter 2025
We are delighted to announce the release of our International Newsletter which will give you an insight into the work we are doing to bring life-enhancing education to an international audience.
-
Read more about Cadaveric Hands-On Surgery Courses – January 2026Cadaveric Hands-On Surgery Courses – January 2026
Our Surgical Team here at The Christie are bringing a unique opportunity for qualified surgeons, trainees and early career surgeons to experience a hands-on cadaveric surgery course this coming January.